Roxana M. Reyes - Publications

Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.

Journal: Journal for immunotherapy of cancer

Published: July 08, 2026

Expression of LIFR in tumor and SHOC2, YAP1 in plasma mRNA as potential biomarkers in KRAS G12C NSCLC.

Journal: Scientific reports

Published: February 19, 2026

Retrospective Cohort Study of Intrapericardial Cisplatin for Risk Reduction of Malignant Pericardial Effusion Recurrence.

Journal: Current oncology (Toronto, Ont.)

Published: June 29, 2025

Landscape and clinical implications of EGFR exon 20 insertions in non-small cell lung cancer patients.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 05, 2024

Efficacy and safety of lorlatinib in patients with ALK- and ROS1-rearranged metastatic non-small cell lung cancer treated within the compassionate use program in Spain.

Journal: Cancer treatment and research communications

Published: November 03, 2024

Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non-Small-Cell Lung Cancer.

Journal: Clinical lung cancer

Published: August 22, 2023

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.

Journal: Thrombosis research

Published: June 12, 2023

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 19, 2022

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report.

Journal: JTO clinical and research reports

Published: September 25, 2022

Durvalumab consolidation in patients with unresectable stage III non-small cell lung cancer with driver genomic alterations.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 13, 2022

Spotlight on Camrelizumab in Advanced Squamous Lung Cancer: Another Feather in the Cap of Chinese Checkpoint Inhibitors.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: January 03, 2022

Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry.

Journal: JAMA oncology

Published: November 24, 2021